Swiss Biotech NBE Therapetics procures $22 mln Series C

NBE-Therapeutics AG, a Swiss biotech firm, has raised $22 million in Series C financing.

NBE-Therapeutics AG, a Swiss biotech firm, has raised $22 million in Series C financing. Boehringer Ingelheim Venture Fund and the PPF Group led the round.

Source: Press Release